[18F]fluorodeprenyl-D2 PET can detect and monitor astrogliosis in anti-LGI1-IgG autoimmune encephalitis.

Saved in:
Bibliographic Details
Title: [18F]fluorodeprenyl-D2 PET can detect and monitor astrogliosis in anti-LGI1-IgG autoimmune encephalitis.
Authors: Gernert JA; Institute of Clinical Neuroimmunology, LMU University Hospital, LMU Munich, Munich, Germany.; Biomedical Center, Medical Faculty, LMU Munich, Munich, Germany., Sanzo L; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany., Zimmermann H; Institute of Neuroradiology, LMU University Hospital, LMU Munich, Munich, Germany., Thaler FS; Institute of Clinical Neuroimmunology, LMU University Hospital, LMU Munich, Munich, Germany.; Biomedical Center, Medical Faculty, LMU Munich, Munich, Germany., Vogler L; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany., Gnörich JS; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany., Tagnin L; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany., Lindner S; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany., Kugelmann B; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany., Schaefer R; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany., Bischof GN; Life Molecular Imaging GmbH, Berlin, Germany., Katzdobler S; Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Werner RA; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.; Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins School of Medicine, Baltimore, MD, US., Höglinger GU; Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Levin J; Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Franzmeier N; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; The Sahlgrenska Academy, Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, University of Gothenburg, Mölndal and Gothenburg, Gothenburg, Sweden.; Institute for Stroke and Dementia Research, LMU University Hospital, LMU Munich, Munich, Germany., Rauchmann B; Institute of Neuroradiology, LMU University Hospital, LMU Munich, Munich, Germany.; Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany., Perneczky R; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.; Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK.; Ageing Epidemiology Research Unit (AGE), School of Public Health, Imperial College London, London, UK., Kerschensteiner M; Institute of Clinical Neuroimmunology, LMU University Hospital, LMU Munich, Munich, Germany.; Biomedical Center, Medical Faculty, LMU Munich, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Kümpfel T; Institute of Clinical Neuroimmunology, LMU University Hospital, LMU Munich, Munich, Germany.; Biomedical Center, Medical Faculty, LMU Munich, Munich, Germany., Brendel M; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany. Matthias.Brendel@med.uni-muenchen.de.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany. Matthias.Brendel@med.uni-muenchen.de.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. Matthias.Brendel@med.uni-muenchen.de.
Source: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2026 Feb; Vol. 53 (3), pp. 2054-2068. Date of Electronic Publication: 2025 Sep 26.
Publication Type: Journal Article
Journal Info: Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1619-7089
DOI:10.1007/s00259-025-07531-5